News | EVA Pharma

Latest News

EVA Pharma Launches its Immunity Booster Limitless Zinc® Tablets

U.S. Food and Drug Administration (FDA) Approved Remdesivir as the only Treatment for COVID-19

EVA Pharma Launches the First Egyptian Generic for Type 2 Diabetes Treatment Diaflozimet® Tablets

EVA Pharma starts export of COVID-19 Antiviral Avipiravir® Worldwide

FDA Broadens Emergency Use Authorization for Remdesivir to Include All Hospitalized Patients for Treatment of COVID-19

Two Egyptian-Manufactured Medicines are Soon Entering Europe and Canada

EVA Pharma Talent Academy Equips 3 Thousands Pharmacy Students for the Job Market

EVA Pharma Releases 500 Thousand Packs of the Analgesic and Antipyretic Drug Paracetamol under the Trade Name Stopadol®

The Supreme Committee for Viruses Recognizes EVA Pharma as a Partner in the Eradication of Virus C in Egypt

EVA Pharma Explores the Manufacturing of COVID-19 Vaccines with European and American Companies

The Telegraph announced that “Sofosbuvir” and “Daclatasvir” Produced by EVA Pharma are reducing Coronavirus Death Rate

EVA Pharma launches the first Egyptian medication for Chronic Obstructive Pulmonary Disease